Alcohol and HCV Chronic Infection Are Risk Cofactors of Type 2 Diabetes Mellitus for Hepatocellular Carcinoma in Italy by Massimiliano Balbi et al.
Int. J. Environ. Res. Public Health 2010, 7, 1366-1378; doi:10.3390/ijerph7041366 
 
International Journal of 
Environmental Research and 
Public Health 
ISSN 1660-4601 
www.mdpi.com/journal/ijerph 
Article 
Alcohol and HCV Chronic Infection Are Risk Cofactors of Type 
2 Diabetes Mellitus for Hepatocellular Carcinoma in Italy 
Massimiliano Balbi 
1, Valter Donadon 
1,*, Michela Ghersetti 
1, Silvia Grazioli 
1, Giovanni Della 
Valentina 
1, Rita Gardenal 
1, Maria Dal Mas 
1, Pietro Casarin 
1, Giorgio Zanette 
2,  
Cesare Miranda 
2 and Paolo Cimarosti 
3 
1   Department of Medicine, Internal Medicine 3
rd, Pordenone Hospital, Via Montereale 24, Pordenone 
33170, Italy; E-Mails: drbalbim@yahoo.it (M.B.); michela.ghersetti@aopn.fvg.it (M.G.); 
silvia.grazioli@aopn.fvg.it (S.G.); giovanni.dellavalentina@aopn.fvg.it (G.D.V.); 
rita.gardenal@aopn.fvg.it (R.G.); maria.dalmas@aopn.fvg.it (M.D.M.);  
pietro.casarin@aopn.fvg.it (P.C.) 
2   Diabetes Clinic, Pordenone Hospital, Via Montereale 24, Pordenone 33170, Italy;  
E-Mails: giorgio.zanette@aopn.fvg.it (G.Z.); cesare.miranda@aopn.fvg.it (C.M.) 
3  Community Addictions Service, Pordenone Hospital, Via Montereale 24, Pordenone 33170, Italy; 
E-Mail: paolo.cimarosti@aopn.fvg.it 
*  Author to whom correspondence should be addressed; E-Mail: valter.donadon@gmail.com;  
Tel.: +39-0434-399280; Fax: +39-0434-399559. 
Received: 3 December 2009; in revised form: 8 February 2010 / Accepted: 15 March 2010 / 
Published: 29 March 2010 
 
Abstract:  Type  2  diabetes  mellitus  (DM2)  has  been  associated  with  hepatocellular 
carcinoma (HCC) development. To study this relationship, we enrolled 465 HCC patients 
compared  with  618  Cirrhotic  cases  and  490  Controls.  The  prevalence  of  DM2  is 
significantly higher in HCC patients with an Odds Ratio of 3.12 versus Controls. In HCC 
cases with alcohol abuse, the frequency of DM2 is the highest. In our HCC patients, when 
HCV  infection  is  associated  with  alcohol  abuse,  the  liver  cancer  develops  earlier.  In 
addition, multivariate analysis shows that alcohol consumption is an independent risk factor 
for HCC more relevant than HCV infection. 
Keywords:  Hepatocellular  carcinoma;  Type  2  diabetes  mellitus;  HCV  infections;  
alcohol abuse 
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1. Introduction 
 
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third 
leading  cause  of cancer-related deaths  [1]. In recent  years, a significant  increase in  hepatocellular 
carcinoma incidence and mortality rates has been observed in developed countries, but
 the causes of 
this growth are only partially understood. Although the main risk factors for HCC are hepatitis C virus, 
hepatitis B virus (HBV) and chronic alcohol abuse, at least 25% of HCC cases do not have any known 
etiology, suggesting that further risk factors could be responsible for the increasing incidence of HCC. 
Diabetes mellitus has recently been proposed as a risk factor for HCC [2,3]. During the past two 
decades,  the  prevalence  of  diabetes  mellitus,  and  in  particular  of  type  2  diabetes  mellitus,  has 
dramatically  increased  in  many  countries,  including  Italy  [4].  Sedentary  lifestyles,  excessive  food 
consumption and obesity appear to be the main causes of the current diabetes mellitus epidemic in the 
western world [5].  
Previous studies on the association between diabetes mellitus and liver diseases showed that type 2 
diabetes mellitus appears to be a cause of non-alcoholic fatty liver disease (NAFLD) and that cirrhosis 
and hepatitis C virus infection increase the susceptibility to diabetes mellitus [6,7].  
Moreover, conflicting results were reported on the association between diabetes mellitus and solid 
tumors, in particular HCC [3,8-12]. While earlier investigations did not report any association between 
diabetes  mellitus  and  HCC,  recent  data  clearly  indicate  that  diabetes  mellitus  is  a  risk  factor  for  
HCC [13-15].  
However, the precise relation between diabetes mellitus and chronic liver diseases still needs to be 
further investigated. Two recent studies have suggested a synergistic interaction in the HCC occurrence 
among heavy alcohol consumption, chronic viral hepatitis and diabetes mellitus in American blacks 
and whites [16,17]. The aims of our study are to provide a precise assessment on the effect of alcohol 
consumption and HCV infections, alone and as co-factors of diabetes mellitus, on the risk of HCC in 
Italian patients.  
 
2. Methods 
 
2.1. Ethics 
 
This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World 
Medical Association.  
We  performed  a  retrospective,  case-control  study  on  three  groups  of  Caucasian  individuals, 
attending  the  Liver  Unit  and  Diabetic  Clinic  of  3rd  Internal  Medicine  in  the  Pordenone  General 
Hospital (Pordenone, Italy) from January 1994 to June 2006. The 3rd Internal Medicine of Pordenone 
Hospital is a tertiary referral centre for liver disease and diabetes mellitus. This study is a single centre 
investigation and all patients  of the three groups studied were all afferent, directly diagnosed and 
followed-up in the 3rd Internal Medicine of Pordenone Hospital. 
A series of patients with HCC was compared with two different groups: one consisted of patients 
with liver cirrhosis (LC) and the other one, the Controls, included individuals who were treated in our Int. J. Environ. Res. Public Health 2010, 7                 
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Hospital  for  a  wide  spectrum  of  acute  conditions.  The  demographic  features  of  these  groups  are 
summarized in Table 1. 
 
Table 1. Characteristics of the HCC, LC and Control groups. 
  HCC  
(n = 465) 
LC  
(n = 618) 
Controls  
(n = 490) 
P
 
Sex Male n (%)   364 (78.3)  450 (72.8)  385 (78.6)  NS
1 
Age years mean ±  SD  68.5 ±  8.9   64.9 ±  12.2   69.4 ±  13.8   NS
1 
BMI kg/m
2 mean ±  SD  25.2 ±  3.1   25.1 ±  3.2   25.1 ±  2.9   NS
1 
Alcohol abuse n (%)  141 (30.4)  188 (30.5)  46 (9.5)  NS
2 
DM2 n (%)  145 (31.2)  144 (23.3)  62 (12.7)  <0.001
1 
HBV+ n (%)  20 (4.3)  27 (4.4)  5 (1.1)  NS
2 
HCV+ n (%)  177 (38.1)  236 (38.3)  26 (5.3)  NS
2 
Duration of type 2 diabetes  
months, mean ±  SD 
141.5 ±  9.4  140 ±  10.5  N/A  NS
2 
Duration of cirrhosis 
Months, mean ±  SD 
150.2 ±  11.6  144.3 ±  9.6  N/A  0.01 
Child-Pugh score (A, B, C %)  55.5, 24.3, 20.2  69.3, 22.2, 8.5  N/A   
Legend:  HCC  =  hepatocellular  carcinoma,  LC  =  liver  cirrhosis,  SD  =  standard  deviation,  
BMI = body mass index, DM2 = type 2 diabetes mellitus, N/A = not available, NS = not significant 
1P-value of chi-square test 
2P-value of chi-square test for HCC versus LC group. 
 
2.2. Sample 
2.2.1. HCC group 
The HCC group comprised 465 consecutive patients with HCC, of which 398 cases (85.6%) were 
diagnosed by means of cytological or histological examination of hepatic focal lesions. The others 
(14.4%)  were  diagnosed  according  to  the  following  acknowledged  criteria  [18]:  ultrasound 
examination (also by using micro-bubbles of sulfur hexafluoride as contrast dye in the last three years), 
alpha  fetoprotein  (AFP)  >  400  ng/mL,  computerized  tomography  scan  and/or  magnetic  resonance 
imaging of the upper abdomen. Clinical data, biochemical parameters and the antidiabetic treatment 
were considered at the time of HCC diagnosis. 
2.2.2. LC group  
We enrolled 618 patients with liver cirrhosis (LC), matched with the HCC cases by age (± 5 years), 
gender, body mass index (BMI), transaminases, history of diabetes, prevalence of hepatitis B virus and 
hepatitis C virus infections, alcohol consumption and time of admission. These patients were admitted 
to our hospital for diagnosis, staging or therapy of liver cirrhosis. Clinical data, biochemical parameters 
and antidiabetic treatment were considered at the time of recruitment. Int. J. Environ. Res. Public Health 2010, 7                 
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According to Child’s classification of cirrhosis, patients were classified as follows: class A: 55.5%; 
B:  24.3%  and  C:  20.2%.  In  the  cirrhotic  patients,  the  presence  of  HCC  was  ruled  out  through 
ultrasound examinations, CT or MRI of the upper abdomen and AFP checks. 
 
2.2.3. Control group 
 
From 28,740 in-patients of our region, 490 subjects matched with HCC and LC patients by age  
(± 5 years), gender, BMI, history of diabetes and time of admission were recruited. Those who were 
admitted  for  malignancies,  alcohol-related  disease,  viral  liver  disease  and  diabetes  mellitus  were 
excluded from our study, although comorbidity of these conditions was not considered as an exclusion 
criterion.  Therefore,  the  primary  diagnoses  of  admission  were:  heart  failure  (34.9%),  
hypertension  (21.4%),  chronic  obstructive  broncho-pneumopathies  or  pneumonia  (16.5%),  atrial 
fibrillation (7.8%), deep venous thrombosis (6.5%), fever of unknown origin (5.3%), benign tumors 
(4.1%), gastritis (3.5%). 
The  Control  group  subjects  are  not  matched  with  LC  and  HCC  patients  for  HCV  and  HBV 
infection,  alcohol  consumption,  diabetes  mellitus  history  and  antidiabetic  treatment.  In  fact,  our 
purpose  was  to  select  the  Controls  in  order  to  be  sure  that  they  represent  our  region’s  general 
population as regards to HCV, HBV infection, alcohol consumption and diabetes mellitus prevalence 
in subjects of the 60−75 years age group, which is the age interval in which the mean age of our HCC 
patients is located.  
Therefore, the prevalence for the following parameters, as total in the free living population of our 
region  and  in  their  age  interval  of  60−75  years,  compared  to  those  of  the  selected  Controls,  are  
the following:  
  HCV infection: 3.2% total and 5.0% in the age group of 60−75 years of the general population 
as regards to 5.3% of Controls in the present study;  
  HBV infection: 1.2 % in all the general population as to 1.68% in the age group of 60−75 years 
and 1.15 % in Controls; 
  Alcohol abuse: 4.5% in general population as to 9.7% in the 60−75 years age group and 9.5% 
in Controls;  
  Diabetes mellitus : 4.8% in the general population as regards to 12.4% in the age group of 
60−75 years and 12.7% in Controls of this study [19-22]. 
 
2.3. Data Collection 
 
The demographic, clinical and biochemical data of each patient were collected in a computerized 
database. Biochemical parameters were determined at the Pordenone Hospital central laboratory using 
standardized and validated methods.  
Hepatitis B surface antigen (HBsAg), anti-HBV surface antigen (anti-HBs), anti-HBV core antigen 
(anti-HBc), and hepatitis  B e antigen (HBeAg) were determined using commercial assays (Abbott 
Diagnostic  Division,  Wiesbaden;  Germany).  Sera  were  also  screened  for  antibodies  against  HCV  
(anti-HCV) using a third-generation micro particle enzyme immunoassay (AxSYM HCV version 3.0, Int. J. Environ. Res. Public Health 2010, 7                 
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Abbott Diagnostic Division). Positive samples were tested for anti-HCV using a third-generation line 
immunoassay (Immunogenetics, Gent, Belgium) and for serum HCV-RNA using the Roche Amplicor 
version 2.0 (Roche Molecular System, Pleasenton, CA). 
The diagnosis and clinical classification of diabetes mellitus were based on the guidelines of the 
American Diabetes Association [23,24]. In particular, the distinction between type 1 and 2 diabetes 
mellitus, was made according to the following clinical characteristics: age and modality of glucose 
intolerance onset, previous use of antidiabetic medications, occurrence of ketoacidosis, obesity and 
body  fat  distribution,  concomitant  autoimmunity,  positive  family  history  and  HLA  association, 
presence of micro- and macrovascular complications when diabetes was diagnosed.  
A  trained  nurse  assessed  the  alcohol  intake  by  interviewing  the  patients  using  a  standard 
questionnaire. Total alcohol intake was evaluated retrospectively on the basis of a history of lifetime 
consumption, dividing the patient’s life into 10-years periods, and recorded as the average amount of 
ethanol (mL) ingested daily. Each subject was classified according to his/her maximum level of alcohol 
consumption for one or more decades in his/her lifetime in order to avoid underestimation of alcohol 
consumption in subjects with HCC and a history of alcoholic liver disease. Alcohol use was evaluated 
considering an average alcohol content in volume of 5% for beer (a can = 330 mL), 12% for wine  
(a  glass  =  125  mL),  18%  for  aperitifs,  30%  for  digestive  alcoholic  drinks  and  40%  for  liqueurs  
(a measure = 40 mL). A glass of wine, a can of beer or a measure of superalcoholics contain about 16 g 
of ethanol. Alcohol abuse was defined as a daily consumption over 30 g for males and over 20 g for 
females. Average alcohol content was estimated in 5% for beer, 12% wine and 40% spirits [25]. 
 
2.4. Statistical Analysis  
 
Normality  tests  were  performed  on  all  data.  Parametric  data  are  expressed  as  mean  values  ±  
standard deviation (SD). Data with multiple time points variables were analysed by the general model 
ANOVA. Post hoc multiple comparisons were performed using an LSD test when ANOVA testing 
was significant (P ≤ 0.05). To establish univariate associations among variables, the odds ratio (OR) 
with a confidence interval of 95% was calculated, using the simple analysis of the logistic regression. 
Multivariate logistic regression was used to assess the association of HCC with DM2 after adjusting 
for potentially confounding factors. Evaluating the association of DM2 with the risk of HCC using LC 
patients as the Control group, we considered sex, age, body mass index, HBV and HCV infection, 
alcohol abuse, ALT level. Using the Control group, potential confounders included only sex, age, BMI, 
and alcohol abuse. We examined the potential interaction effects between the independent risk factors 
on HCC risk. When assessing if the combined effect of two factors on HCC was greater than the sum 
of the individual effects, we used the Synergy Index (SI) method described by Rothman [26]. A value 
of SI equal to unity was interpreted as indicative of additivity, whereas a value greater than unity was 
indicative of superadditivity and synergism. 
All statistical analyses were performed using SAS v9.1 (SAS Institute Inc., Cary, NC, USA). 
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3. Results 
 
Each subject with diabetes mellitus in the HCC and LC groups showed the clinical and metabolic 
characteristics of type 2 diabetes mellitus. Of note, none of our HCC or liver cirrhosis patients had  
type 1 diabetes mellitus.  
As shown in Table 2, the prevalence of DM2 was 31.2% in the HCC group, 23.3% in the LC group 
and 12.7% in the Controls. The prevalence of DM2 in the three groups were statistically different  
(P < 0.0001), with an OR of 3.12 (CI 2.2−4.4; P < 0.001) in HCC group versus Controls and an OR of 
2.09 (CI 1.5−2.9; P < 0.001) in HCC versus LC cases.  
Etiology of the chronic liver disease, mean age at HCC diagnosis and DM2 prevalence in the HCC 
patients are summarized in Table 3. Notably, alcohol related HCC had a significantly higher prevalence 
of DM2 compared to the HCV-positive group of HCC (36.9% versus 26.5%; P = 0.048).  
 
Table 2. Frequency of type 2 diabetes mellitus in HCC, LC and control groups. 
Subjects 
(n) 
DM2-negative 
n (%) 
DM2-positive 
n (%) 
OR (95% CI)  P 
Total 
-HCC(465) 
Controls (490) 
- LC (618) 
 
320 (68.8) 
428 (87.3) 
474 (76.7) 
 
145 (31.2) 
62 (12.7) 
144 (23.3) 
 
3.12 (2.2-4.4)
a 
2.09 (1.5-2.9)
c 
 
<0.001 
<0.001 
Males 
- HCC (364) 
- Controls (385) 
- LC (450) 
 
246 (67.6) 
334 (86.7) 
341 (75.8) 
 
118 (32.4) 
51 (13.3) 
109 (24.2) 
 
3.14 (2.1-4.6)
b 
1.99 (1.3-2.9)
d 
 
<0.00001 
=0.0002 
Females 
- HCC (101) 
- Controls (105) 
- LC (168) 
 
74 (73.3) 
94 (89.5) 
133(79.2) 
 
27 (26.7) 
11 (10.5) 
35 (20.8) 
 
3.11 (1.3-7.4)
e 
2.59 (1.2-5.9)
f 
 
=0.002 
=0.008 
OR: Odds ratio; CI: Confidence interval; 
aHCC versus Controls; 
CHCC versus LC; 
bHCC versus 
Controls; 
d HCC versus LC; 
eHCC versus Controls; 
f HCC versus LC.  
Table  3.  Etiology,  mean  age  and  prevalence  of  type  2  diabetes  mellitus  in  465  HCC 
patients. (mean ±  SD). 
Etiology  HCC n (%)  Age (yr)  Prevalence of DM2 (%) 
HBV  20 (4.3)  63.3 ±  10.3
a,b  3 (15.0) 
HCV  177 (38.1)  71.5 ±  7.3
 a,b,c,d,e  47 (26.5)
f 
Alcohol  141 (30.4)  66.7 ±  8.5
 e  52 (36.9)
f 
HBV+HCV  8 (1.7)  60.8 ±  12.8
 a  2 (25.0) 
HBV+alcohol  9 (1.9)  62.9 ±  9.3
 a,c  2 (22.2) 
HCV+alcohol  81 (17.4)  67.7 ±  9.3
 a,d  27 (33.3) 
HBV+HCV+alcohol  2 (0.4)  68.4 ±  10.3  0 
Cryptogenic  27 (5.8)  68.6 ±  9.3  19 (70.3)
  
aP < 0.001; 
bP < 0.001; 
cP < 0.001; 
d,eP < 0.001; 
fP = 0.048. Int. J. Environ. Res. Public Health 2010, 7                 
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3.1. Age at Diagnosis of HCC According to Etiology of Liver Disease 
In  the  subgroup  of  patients  with  HCV  infection  associated  to  alcohol  abuse,  the  age  of  HCC 
diagnosis is similar to the patients with only alcohol abuse as a risk factor for HCC (66.7 ±  8.5 years), 
but  significantly  lower  than  in  the  subgroup  of  patients  with  HCV  infection  (67.7  ±   9.3  versus  
71.5 ±  7.3 years; P < 0.001) (Table 3). 
3.2. Multivariate Analysis 
 Multivariate logistic regression analysis was used to assess the independent role of different variables 
in  HCC patients considering Controls as the comparison group (Table 4). HCV infection, alcohol 
abuse and DM2 are independent variables associated with risk of HCC and alcohol abuse shows the 
highest risk of HCC occurrence (OR = 121.2; CI 61.9–233.7; P < 0.001).When considering cirrhotic 
patients as comparison groups the OR for DM2 was 1.4 (CI 1.0–1.9; P = 0.01). 
Table 4. Multivariate analysis for HCC risk. 
HCC  OR (95% CI)  P 
DM2-positive  2.2 (1.2–4)  =0.011 
HCV-positive  106.5 (58.2–194.9)  <0.001 
ALCOHOL-positive  121.2 (61.9–233.7)  <0.001 
OR: Odds ratio; CI: Confidence interval. 
3.3. Time Interval from Type 2 Diabetes Mellitus Onset to HCC Diagnosis 
The data collected in the records of our Diabetes Clinic show that in 122 patients (84.9%), DM2 
was diagnosed at least six months before the onset of HCC, while in only 23 patients (15.1%) DM2 
was recognized after the diagnosis of HCC. 
The time interval between DM2 diagnosis and HCC onset was exactly calculated: diabetes was 
found to be present prior to the HCC diagnosis for a mean time of 141.5 ±  9.4 months. 
In the subgroup with pre-existing DM2, the time interval until the diagnosis of HCC was longer in 
insulin  treated  patients  than  in  those  treated  with  antidiabetic  oral  agents  (171.5  ±   87.6  versus  
118.7 ±  95.2 months; P < 0.05) (Table 5). 
Table 5. Duration of DM2 before HCC diagnosis and antidiabetic therapy. 
HCC  Months (mean ±  SD)  P 
Insulin therapy  171.5 ±  87.6 
<0.05 
AOA therapy  118.7 ±  95.2 
Total   141.5 ±  9.4    
SD: standard deviation. Int. J. Environ. Res. Public Health 2010, 7                 
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3.4. Interactive Effect of the Association among Type 2 Diabetes Mellitus and HCV Infection  
 
As regards to the effect of HCV as cofactor of DM2 , we found an OR for HCC of 2.7 (CI 1.9−4.0; 
P < 0.0001) in HCC patients versus Controls with HCV infection alone and of 36.9 (CI 21.6−60.5;  
P  <  0.0001)  if  HCV  infection  is  associated  with  DM2,  with  a  Rothman’s  Synergy  Index  of  9.2.  
(CI 4.7−17.2) (Table 6). 
Table  6.  Interactive  effect  of  the  association  of  type  2  Diabetes  Mellitus  with  HCV 
infection in HCC versus Controls group. 
 HCV  DM2  OR (95% CI)  P  SI 
No  No  1.0     
Yes  No  2.7 (1.9–4.0)  <0.0001 
Yes  Yes  36.9 (21.6–60.5)  <0.0001  9.2 (4.7–17.2) 
OR: Odds ratio; CI: Confidence interval; SI: Rothman’s Sinergy Index. 
 
3.5. Interactive Effect of the Association among Type 2 Diabetes Mellitus and Alcohol Abuse  
 
Evaluating  the  association  among  DM2  and  alcohol  abuse  in  HCC  versus  Controls  group,  the 
alcohol  abuse  alone  shows  an  OR  for  HCC  of  3.7  (CI  2.5−5.4;  P  <  0.0001)  and  of  49.0  (CI 
21.5−111.8; P < 0.0001) when alcohol is associated to DM2, with a Rothman’s Synergy Index of 9.8 
(CI 4.9−18.4) (Table 7). 
Table  7.  Interactive effect of the association of type 2 Diabetes Mellitus with Alcohol 
abuse in HCC versus Controls group.  
Alcohol  DM2  OR (95% CI)  P  SI 
No  No  1.0     
Yes  No  3.7 (2.5–5.4)  <0.0001 
Yes  Yes  49.0 (21.5–111.8)  <0.0001  9.8 (4.9–18.4) 
OR: Odds ratio; CI: Confidence interval; SI: Rothman’s Sinergy Index. 
4. Discussion 
Our study shows that HCV infection, alcohol abuse and DM2 are independent risk factors for HCC. 
Alcohol abuse seems to have a stronger effect on HCC risk, more than HCV infection and DM2 by 
itself. In fact, the OR for HCC is significantly higher when DM2 is associated with alcohol abuse 
(49.0) than with chronic HCV infection (36.9). In addition, alcohol consumption significantly lowers 
the mean age of HCC occurrence in HCV-positive patients of our population and the prevalence of 
DM2 that is higher in patients with alcohol abuse than in HCV-positive patients.  
In this study, every HCC and cirrhotic patient with abnormal glucose tolerance showed clinical and 
pathophysiological characteristics of DM2. The results of our study are consistent with the theory of 
the biological mechanisms underlying the epidemiological association between diabetes mellitus and 
cancer. In fact, this hypothesis postulates that the diabetes-cancer association is likely to be related to Int. J. Environ. Res. Public Health 2010, 7                 
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insulin resistance and consequent hyperinsulinemia, which are typical features in the majority of type 2 
diabetes mellitus patients. Ten years ago, McKeown-Eyssen [27] and Giovannucci [28] observed that 
risk factors for cancer and insulin resistance in developed countries are almost the same. To explain 
this analogy, they suggested that protracted exposure to hyperinsulinemia increases the levels of IGF-1, 
which plays a pivotal role in carcinogenesis (insulin-cancer hypothesis) [29]. In addition, the predictive 
value of hyperinsulinemia on total cancer mortality [9] and fatal liver tumor incidence [30] has been 
demonstrated in non-diabetic subjects by two recent prospective analysis. 
The  mechanisms  through  which  alcohol  consumption  and  diabetes  mellitus  promote  the 
development of HCC are unknown. Although moderate alcohol intake is associated with a reduced risk 
of DM2, high alcohol consumption seems to have an increased risk of DM2 compared to moderate 
consumers  [31].  There  is  a  supposed  role  of  oxidative  stress,  like  during  the  heavy  alcohol 
consumption, in the onset and progression of diabetes mellitus and its complications, related to chronic 
hyperglycemia.  In  diabetes  mellitus  patients,  an  increased  blood  glucose  level  may  stimulate 
glycosylation of proteins, including hemoglobin, leading to an increase in the release of iron from 
hemoglobin and further production of free radicals causing oxidative stress, in fact the finding of high 
concentration of serum ferritin in patients with diabetes mellitus may reflects an increased body iron 
stores [32-36]. The fact that iron is a powerful pro-oxidant and that oxidative stress is increased in 
impaired  glucose  tolerance  states,  suggests  a  possible  role  for  oxidative  stress  in  pathogenesis  of 
diabetes mellitus and its complications on the liver, such as cirrhosis. It is also possible that alcohol-
induced oxidative stress may increase the susceptibility of patients  with diabetes mellitus to DNA 
damage and HCC development. Moreover, heavy alcohol consumption could directly induce hepatic 
cellular injury and toxicity leading to the development of liver fibrosis and cirrhosis [37]. In addition, 
oxidation  and  metabolism  of  ethanol in  the liver by microsomal  enzymes may contribute to  liver 
carcinogenesis [38].Generation of acetaldehyde, and oxygen free radical during ethanol metabolism is 
also associated with development of alcohol related liver disease through oxidative stress [39]. 
The association between chronic ethanol abuse and the development of cirrhosis, as well between 
cirrhosis and the development of HCC is well documented. Ethanol and its metabolism affect cell 
signaling pathways that regulate normal and abnormal hepatocyte function, proliferation and apoptosis, 
deplete the body’s natural antioxidant supply of glutathione and increase oxygen radical production, 
leading to release of proinflammatory cytokines [40]. Oxidative stress is a central factor involved in 
alcohol-induced liver injury and a critical event in carcinogenesis. [41]. Moreover intake of alcohol 
results in decreased hepatic levels of vitamin A, that plays an important role in controlling cell growth, 
differentiation and apoptosis, as well on carcinogenesis [42]. 
In type 2 diabetes mellitus patients the mortality ratio for liver related events is higher than that for 
cardiovascular events [43]. However, patients with DM2 often suffer from liver disease, and diabetes is 
a recognized cause of NAFLD and cryptogenic cirrhosis. In fact, it is well-known that the natural 
history  of  NAFLD  might  progress,  over a period of many years, from  steatosis  to  steatohepatitis, 
cirrhosis and, sometimes, to HCC [6]. On the other hand, 20% of patients with cirrhosis have overt 
diabetes (hepatogenous diabetes) and 60% have impaired glucose tolerance [44]. Thus, the association 
between diabetes and cirrhosis is complex and reciprocal. Int. J. Environ. Res. Public Health 2010, 7                 
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To evaluate the interactions between DM2, HCV infection, alcohol abuse and HCC, we performed a 
single centre, retrospective case-control study on HCC patients comparing them, not only to a group of 
Control subjects without liver diseases and diabetes mellitus, but also to a series of cirrhotic patients.  
Our study shows that the prevalence of DM2 in the LC group is intermediate between those of the 
HCC and Controls, indicating that the underlying liver cirrhosis is not the only cause of diabetes in 
HCC patients. The evidence that DM2, HCV infections and alcohol abuse are a risk factor for HCC in 
our patients is demonstrated by multivariate analyses, which show an OR for HCC of 2.2 for DM2, 
106.5 for HCV infections and 121.2 for alcohol abuse. The prevalence of DM2 is significantly higher 
in HCC patients with alcohol abuse and have a synergic effect on HCC occurrence more evident than 
the association between DM2 and HCV infection.  
The precise temporal relation between the onset of type 2 diabetes mellitus and diagnosis of HCC is 
only partially understood. A previous prospective study [11], conducted in a large cohort of males with 
and  without  diabetes  mellitus,  investigated  for  the  first  time,  the  temporal  relationship  between 
diabetes and HCC, showing a two-fold increase of HCC incidence among patients with diabetes. Our 
study showed that DM2 is present for a mean of 141 months before the diagnosis of HCC.  
A new finding of the current  study is  the demonstration of synergistic (excess  over additivity) 
effects on HCC between HCV infections, alcohol abuse and diabetes, independent of each other’s 
effects. Indeed the combined effect of viral hepatitis C and diabetes and alcohol abuse and diabetes 
were both more than the sum of the individual effects as showed by the Rothman’s Synergy Index that 
is more relevant for alcohol abuse than for HCV infection as cofactors of diabetes mellitus on HCC 
development. This suggest that heavy alcohol consumption, in addition to its own direct effects may 
exacerbate  the  effect  of  diabetes  mellitus  and  chronic  hepatitis  C  virus  infection  on chronic liver 
diseases and HCC. 
 
5. Conclusions 
 
The  results  of  our  study,  therefore,  have  important  implications  in  the  clinical  management  of 
diabetes mellitus, particularly in patients with DM2 and chronic liver diseases, because we found that 
they are at  high-risk for HCC. This  observation is of primary relevance to the implementation of 
prevention policies and to encourage the most adequate and cost-effective programs of surveillance in 
cirrhotic patients.  
Thus, our data suggests that patients with DM2 and chronic liver disease should first control their 
diabetes through diet and changes in lifestyle, to decrease their weight and increase physical activity.  
In  our  study  HCV  infection,  alcohol  abuse  and  DM2  are  independent  predictors  of  HCC 
development. Furthermore our data show that in our population, alcohol consumption, DM2 and HCV-
positivity exert synergistic effects on risk of HCC. These factors are likely contributors to the rising 
incidence of HCC in our and other developed countries. Moreover, public health considerations should 
prompt the study of HCC prevention strategies among high-risk individuals. In the meantime, it would 
seem prudent for patients having chronic hepatitis infections or diabetes mellitus consider abstaining 
from alcohol consumption to reduce the effect of alcohol when combined with these other risk factors.  
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